Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Autoimmune disorder treatment using RXR agonists

Autoimmune disorder treatment using RXR agonists

US Patent 11246845 · Granted Feb 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
Treatment of diseases by concurrently eliciting remyelination effects and immuno2025
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
VISTA-Ig constructs and the use of VISTA-Ig for treatment of autoimmune, allergi2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders2024
Vista antagonist and methods of use2024
Vista antagonist and methods of use2024
Autoimmune disorder treatment using RXR agonists2023
Autoimmune disorder treatment using RXR agonists2023